Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-07. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
In September 2008, Aboitiz Equity Ventures decided to quit the shipping business to focus on its core businesses, namely power and financial services, and announced the sale of its controlling 77% stake in Aboitiz Transport System to KGLI‑NM Holdings, a joint venture between Negros Navigation and Dutch investors, with plans to acquire the remaining shares and potentially delist the company, but due to financing difficulties during the global financial crisis, KGLI‑NM was unable to complete the full buyout, paid only a P100 million option fee, and eventually withdrew its offer in May 2009, terminating the agreement. On December 1, 2010, Aboitiz Equity Ventures sold its transport business to Negros Navigation Co. Inc. (NENACO) for US$105 million, transferring all logistics and shipping operations under new ownership. At the same time, the China–ASEAN Investment Cooperation Fund, a Netherlands-based private equity firm owned by the Government of the People's Republic of China, acquired a controlling stake in NENACO through an equity infusion. In 2012, the company was reorganized and rebranded as 2GO Group Inc. with its brands SuperFerry, SuperCat, and Cebu Ferries merged with Negros Navigation to form 2GO Travel. In 2016, SM Investments Corporation (SMIC) and Chelsea Logistics and Infrastructure Holdings Corp. (owned by Dennis Uy) jointly acquired a major stake in 2GO Group Inc. In 2021, Chelsea Logistics sold its shares to SMIC, making 2GO a full subsidiary of SM Investments Corporation.
=== October === October 10, 2008: Singapore First Asian country to slip into a recession since the credit crisis began. Singapore's export-dependent economy shrank an annualized 6.3% in the third quarter after a revised 5.7% contraction in the second quarter; its first recession since 2002. Growth has faltered in Singapore as a result of less demand for exports, a reduction in tourism, and the end of the real-estate boom. Singapore's manufacturing sector had declined 4.9% in the previous quarter.
fibrinogen: lyophilised pooled human concentrate thrombin: This used to be of bovine origin; modern formulations contain human thrombin. The two components are mixed immediately before application. The formulations also contain calcium salts. Formulations from different manufacturers may also contain aprotinin, fibronectin, plasminogen, and factor XIII.
A flexible intermediate bulk container, FIBC, big bag, bulk bag, or super sack is a standardized container in large dimensions for storing and transporting granular products. It is often made of a woven synthetic material.
Sources: en.wikipedia.org
To Killanin's surprise, a postal ballot of IOC members decided in February that SANOC had made sufficient progress in to be invited to the 1968 Games, on the understanding that its team would be multiracial and remaining discrimination would be ended by the 1972 Games. This verdict prompted the SCSA countries to withdraw; in the US, the American Committee on Africa organised a boycott by African American athletes; the Eastern Bloc also threatened a boycott. The Mexican organising committee was worried that its Games would be a fiasco and asked the IOC to reconsider. Brundage flew to South Africa in an unsuccessful bid to ask it to withdraw voluntarily. The IOC executive board met on 21 April 1968 to seek a diplomatic formula under which to exclude South Africa, finally agreeing that "due to the international climate, the executive committee was of the opinion it would be most unwise for South Africa to participate".
tetramer A molecular aggregate consisting of four subunits. The term is often used to refer to protein complexes composed of four proteins, e.g. haemoglobin, or to individual proteins composed of four polypeptides. Compare monomer, dimer, and trimer.
=== Exposure route considerations in CNT toxicology === Pulmonary exposure: Inhalation of airborne CNTs during manufacturing or handling poses the highest risk. CNTs can induce dose-dependent pulmonary toxicity, including granuloma formation, fibrosis, and inflammation. MWCNTs, due to their fiber-like structure, are particularly prone to eliciting asbestos-like responses. SWCNTs may translocate systemically but generally exhibit less chronic pulmonary toxicity. Dermal and consumer exposure: Intact skin provides a barrier to CNT penetration, though localized cutaneous inflammation has been reported while evidence suggests limited systemic health impact. Oral and systemic exposure: Oral ingestion of CNTs typically results in low bioavailability and rapid excretion, with significant effects observed only at high doses. Systemic exposure via intravenous or intraperitoneal routes is primarily relevant in experimental or therapeutic contexts.
=== Protein === This 1686-amino acid protein belongs to the ADAMTS family and is one of 19 members known in humans. It is a large, multi-domain enzyme that undergoes extensive post-translational modifications, including N- and O-linked glycosylation, chondroitin sulfate attachment, and potential C-mannosylation and O-fucosylation of the thrombospondin (TSP) type 1 domains. The domain structure from the N-terminus to the C-terminus consists of:
== Background == In 2012, Mali experienced a deep political and security crisis due to the insurgency in its northern regions. A military coup in Bamako and the rise of armed Tuareg groups, such as the National Movement for the Liberation of Azawad (MNLA) and jihadist elements, destabilised the region further. By 2013, the Malian government, supported by French forces under Operation Serval, as well as troops from Chad and other African nations, managed to recapture much of the north from jihadist control. However, the MNLA had taken advantage of the power vacuum left by retreating jihadists to regain control over key cities in northern Mali, particularly Kidal, a strategic town in the region of Azawad. In this context, tensions escalated between the MNLA and the Malian government over control of Kidal and the organisation of the upcoming presidential elections. While initially refusing to allow elections in Kidal, the MNLA eventually agreed to permit them in July 2013, provided that United Nations troops secured the voting process across Azawad. The Malian government, however, insisted that its own military forces must be present in Kidal to oversee security, which led to further friction between the two parties. By June 2013, tensions boiled over when the MNLA arrested 180 individuals in Kidal, accusing them of being Malian spies or infiltrators. Accusations of violence, pillaging, and ethnic targeting by the MNLA against black populations such as the Songhai, Peulh, and Bella people, were made.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.